<DOC>
	<DOC>NCT00520754</DOC>
	<brief_summary>Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in Children</brief_summary>
	<brief_title>Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in Children</brief_title>
	<detailed_description />
	<mesh_term>Cough</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>infants from 2 to 24 months both inclusive suffering from recurrent cough associated with other allergic symptoms hospitalized for respiratory or allergy related problems laboratory results within normal ranges height and weight between percentile 5 and 95 having taken any of the disallowed medication suffering form any disorder history of sleep apnea having concomitant chronic disease known relevant renal, hepatic, cardiac or metabolism dysfunction known alcohol or drug addiction, severe psychiatric disease for the parent/guardian</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>levocetirizine dihydrochloride Xyzal tablets</keyword>
</DOC>